TrialThe Journal of infectious diseases2026
Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial.
Fajri Gafar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.